ESG Summary Report

Overview

The report presents Biocon's FY21 ESG performance through an Unconditional Equity model focused on patient access, people, communities and environmental stewardship. It highlights 3.1 million patients reached globally through biosimilars, a Biocon Group employee base of 13,609 and 257,214 learning hours. Environmental highlights include an 18% reduction in absolute Scope 1 and Scope 2 emissions versus FY20 and 53% of electricity from green power.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Condensed report
Fiscal year: 2021
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services